A 27-year-old man with headache, fever, limb weakness and inarticulate speech

A 27-year-old man with headache, fever, limb weakness and inarticulate speech

Bibliographic Details
Main Authors:	CUI Li-ying, MA Ling-yan, LU Qiang, LI Xiu-li
Format:	Article
Language:	English
Published:	Tianjin Huanhu Hospital 2013-01-01
Series:	Chinese Journal of Contemporary Neurology and Neurosurgery
Subjects:	Meningitis cryptococcal Tuberculosis meningeal Amphotericin B Flucytosine Case reports
Online Access:	http://www.cjcnn.org/index.php/cjcnn/article/view/652/650

Similar Items

A 27-year-old man with headache, fever, limb weakness and inarticulate speech
by: Xiu-li LI, et al.
Published: (2013-01-01)

Prevalence of cryptococcal meningitis among people living with human immuno-deficiency virus and predictors of mortality in adults on induction therapy in Africa: A systematic review and meta-analysis
by: Seke G. Y. Muzazu, et al.
Published: (2022-09-01)

Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV-associated cryptococcal meningitis: a prospective multicenter study in China
by: Ting Zhao, et al.
Published: (2022-08-01)

Short-Course Rather Than Low-Dose Amphotericin B May Exert Potential Influence on Mortality in Cryptococcal Meningitis Patients Treated With Amphotericin B Plus Flucytosine Alone or in Combination With Fluconazole
by: Lijun Xu, et al.
Published: (2019-09-01)

AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial
by: David S. Lawrence, et al.
Published: (2018-11-01)

Symptomatic Cryptococcal Meningitis with Negative Serum and Cerebrospinal Fluid Cryptococcal Antigen Tests
by: Nanfuka V, et al.
Published: (2021-09-01)

Time to embrace access programmes for medicines: lessons from the South African flucytosine access programme
by: Amir Shroufi, et al.
Published: (2020-06-01)

Induction-phase treatment costs for cryptococcal meningitis in high HIV-burden African countries: New opportunities with lower costs [version 2; peer review: 2 approved, 1 approved with reservations]
by: Amir Shroufi, et al.
Published: (2022-03-01)

Induction-phase treatment costs for cryptococcal meningitis in high HIV-burden African countries: New opportunities with lower costs [version 3; peer review: 3 approved]
by: Amir Shroufi, et al.
Published: (2022-06-01)

Cost-effectiveness analysis of flucytosine as induction therapy in the treatment of cryptococcal meningitis in HIV-infected adults in South Africa
by: Jacqui Miot, et al.
Published: (2021-04-01)

MRSA bacteraemia complicating amphotericin B treatment of cryptococcal meningitis
by: J Scriven, et al.
Published: (2013-09-01)

Cryptococcal meningitis: An under-reported disease from the hills of Uttarakhand: A hospital-based cross-sectional study
by: Aroop Mohanty, et al.
Published: (2019-01-01)

Diagnostic and therapeutic approach to chronic meningitis in Brazil: a narrative review
by: Guilherme Diogo Silva, et al.
Published: (2022-11-01)

An Unusual Presentation of Postural Headache Caused by Cryptococcus neoformans Meningitis in an Elderly Person
by: Shang-Lin Hsieh, et al.
Published: (2008-09-01)

Clinical analysis of 26 cases with cryptococcal meningitis
by: Wei-wei HU, et al.
Published: (2014-08-01)

Combination Versus Monotherapy for the Treatment of HIV Associated Cryptococcal Meningitis
by: Shashank Anant Vaidhya, et al.
Published: (2015-02-01)

Case report: Reversible encephalopathy associated with liposomal amphotericin B in a patient with cryptococcal meningitis
by: Si Luo, et al.
Published: (2022-11-01)

Case Report: Cryptococcal eosinophilic meningitis in a patient with Hodgkin lymphoma
by: Fang Zhang, et al.
Published: (2022-09-01)

Minimum concentration of Amphotericin B in serum according to the formulation, dose, and daily or prolonged intermittent therapeutic regimen
by: Leticia Aparecida Schiave, et al.

Disseminated and cutaneous cryptococcosis by C. neoformans VNI in an immunocompetent patient
by: Fernanda Cristina A Maranhão, et al.
Published: (2020-05-01)

Diagnosis of cryptococcal encephalitis in a patient with mature B-cell lymphoblastic leukemia
by: Lev Nikolaevich Gotman, et al.
Published: (2010-03-01)

Emerging fluconazole resistance: Implications for the management of cryptococcal meningitis
by: Edward Mpoza, et al.
Published: (2018-03-01)

Is it possible to differentiate tuberculous and cryptococcal meningitis in HIV-infected patients using only clinical and basic cerebrospinal fluid characteristics?
by: J E Vidal, et al.
Published: (2017-02-01)

Cytomegalovirus viremia as a risk factor for mortality in HIV-associated cryptococcal and tuberculous meningitis
by: Caleb P. Skipper, et al.
Published: (2022-09-01)

Cerebral cryptococcoma successfully treated by isavuconazole in an immunocompetent patient: A case report
by: Luis Guilherme Ramanzini, et al.
Published: (2023-03-01)

Cryptococcal meningitis in an immunocompetent young adult: A rare occurrence
by: Prabhu Kiran Vanka, et al.
Published: (2020-01-01)

Flow cytometry pattern in the diagnosis of cryptococcal meningitis in HIV-infected patients
by: V Wiwanitkit, et al.
Published: (2002-09-01)

Fine needle aspiration diagnosis of cryptococcal lymphadenitis: A window of opportunity
by: Suchitha S, et al.
Published: (2008-01-01)

Cryptococcus infection in a non-HIV patient: a case report
by: Charmian D. Sittambalam, et al.
Published: (2012-10-01)

Preemptive Therapy for Cryptococcal Meningitis: A Valid Strategy for Latin America?
by: José E. Vidal
Published: (2016-05-01)

Cryptococcal Meningitis: Differences between Patients with and without HIV-Infection
by: Chutithep Teekaput, et al.
Published: (2023-03-01)

Emergencies related to HIV infection and treatment (part 1)
by: Amit Chandra, et al.
Published: (2013-09-01)

Tuberculosis preventive therapy (TPT) to prevent tuberculosis co-infection among adults with HIV-associated cryptococcal meningitis: A clinician’s perspective
by: John Kasibante, et al.
Published: (2020-08-01)

Funding for research on cryptococcal disease: an analysis based on the G-finder report
by: Iraine Duarte, et al.
Published: (2024-03-01)

Sterile Cerebrospinal Fluid Culture at Cryptococcal Meningitis Diagnosis Is Associated with High Mortality
by: Caleb P Skipper, et al.
Published: (2022-12-01)

Starting ART following cryptococcal meningitis:The optimal time has yet to be defined
by: T A Bicanic, et al.
Published: (2013-09-01)

A review of the management and outcome of patients admitted with cryptococcal meningitis at a regional hospital in KwaZulu-Natal province
by: Andrew J. Ross, et al.
Published: (2019-09-01)

Correlation of anti-fungal susceptibility with clinical outcomes in patients with cryptococcal meningitis
by: Lee Chen-Hsiang, et al.
Published: (2012-12-01)

Diabetes mellitus as a risk factor for cryptococcal meningitis in immunocompetent
by: Roshan Acharya, et al.
Published: (2020-01-01)

Ambulatory induction phase treatment of cryptococcal meningitis in HIV integrated primary care clinics, Yangon, Myanmar
by: Clare E. Warrell, et al.
Published: (2021-04-01)